Price T Rowe Associates Inc Burning Rock Biotech LTD Transaction History

Price T Rowe Associates Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$1.73 - $2.95 $22,323 - $38,066	-12,904 Reduced 3.8%	326,360 $734,000
Q3 2022 Nov 14, 2022	BUY	$2.39 - $3.96 $23,206 - $38,451	9,710 Added 2.95%	339,264 $811,000
Q2 2022 Aug 15, 2022	SELL	$1.75 - $10.44 $38,160 - $227,654	-21,806 Reduced 6.21%	329,554 $959,000
Q1 2022 May 16, 2022	SELL	$6.7 - $10.23 $1.62 Million - $2.47 Million	-241,862 Reduced 40.77%	351,360 $3.26 Million
Q4 2021 Feb 14, 2022	BUY	$9.43 - $17.14 $365,337 - $664,037	38,742 Added 6.99%	593,222 $5.65 Million
Q3 2021 Nov 15, 2021	SELL	$17.37 - $27.92 $49,573 - $79,683	-2,854 Reduced 0.51%	554,480 $9.91 Million
Q2 2021 Aug 16, 2021	SELL	$26.14 - $37.45 $4.37 Million - $6.27 Million	-167,339 Reduced 23.09%	557,334 $16.4 Million
Q1 2021 May 17, 2021	SELL	$23.5 - $39.58 $3.2 Million - $5.4 Million	-136,354 Reduced 15.84%	724,673 $19.5 Million
Q4 2020 Feb 16, 2021	BUY	$22.55 - $30.87 $19.4 Million - $26.6 Million	861,027 New	861,027 $19.9 Million

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $642M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.